Your browser doesn't support javascript.
loading
Safety Procedures to Work with West Nile Virus in Biosafety Level 3 Facilities.
Green, Freedom M; Ronca, Shannon E.
Affiliation
  • Green FM; National School of Tropical Medicine, Feigin Biosafety Level 3 Facility, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Ronca SE; National School of Tropical Medicine, Feigin Biosafety Level 3 Facility, Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. Shannon.Ronca@bcm.edu.
Methods Mol Biol ; 2585: 205-210, 2023.
Article in En | MEDLINE | ID: mdl-36331776
ABSTRACT
West Nile virus (WNV) can cause severe and sometimes fatal disease, but we do not have treatments or therapeutics to manage these outcomes. Since its introduction to the USA in 1999, WNV has been handled in a biosafety level 3 laboratory to decrease risk to researchers, requiring strict safety protocols and important considerations with planning experiments. Recent changes in US guidelines suggest that WNV can be handled at a lower biosafety level due to its endemicity in the USA and generally minor symptoms, but some research still requires the use of the agent at biosafety level 3. This chapter will briefly discuss the considerations of biosafety when working with WNV.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: West Nile Fever / West Nile virus Limits: Humans Language: En Journal: Methods Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: West Nile Fever / West Nile virus Limits: Humans Language: En Journal: Methods Mol Biol Journal subject: BIOLOGIA MOLECULAR Year: 2023 Document type: Article Affiliation country: United States